Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 14, 2026
Therapeutic targeting of folate receptor alpha (FRα) by antibody-polymer-drug conjugate in testicular germ cell tumors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 12, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 27, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Implementing a context-augmented large language model to guide precision cancer medicine.
Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025
A context-augmented large language model for accurate precision oncology medicine recommendations.
Journal: Cancer cell
Published: July 15, 2025
Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Journal: Cancer cell
Published: June 10, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.
Journal: Nature communications
Published: February 05, 2025
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.
Journal: European urology oncology
Published: August 19, 2024
Last Updated: 09/26/2026